{"id":16923,"date":"2016-08-11T14:00:20","date_gmt":"2016-08-11T14:00:20","guid":{"rendered":"https:\/\/ipo.org\/?p=16923"},"modified":"2016-08-16T17:45:57","modified_gmt":"2016-08-16T17:45:57","slug":"section-101-way-ahead","status":"publish","type":"post","link":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/","title":{"rendered":"Life Sciences &#038; Section 101: The Way Ahead"},"content":{"rendered":"<p>The U.S. Supreme Court\u2019s recent decision not to grant certiorari in <i>Ariosa v. Sequenom <\/i>was a sharp disappointment to many inventors and patent owners who had hoped the Court would revisit and clarify its views on patent eligibility after its decisions in <i>Mayo<\/i> and <i>Alice<\/i>. But that was not to be. As a result, the two industries most wounded by <i>Mayo<\/i> and <i>Alice<\/i> &#8212; life sciences and computer software &#8212; must look for paths ahead without any reprieve from the Justices. Recent Section 101 cases from the U.S. Federal Circuit and ex parte PTAB decisions can serve as signposts for both the life sciences and software industries. Our industry-specific panel is made up of a technically-savvy in-house counsel and two top law firm patent prosecutors. They will discuss cases such as:<\/p>\n<ul>\n<li><i>Rapid Litigation v. CellzDirect<\/i>, where in early July, the U.S. Federal Circuit panel reversed a district court\u2019s holding that claims to a method of isolating and preserving liver cells were patent-ineligible. The appellate court held that the claims did not encompass a judicial exception (<b>step one <\/b>of the <i>Mayo\/Alice<\/i> analysis). The same kind of analysis helped save patents involving self-referential software databases in <i>Enfish v. Microsoft<\/i> this spring.<\/li>\n<\/ul>\n<ul>\n<li><i>Bascom v. AT&amp;T<\/i>, where in June the U.S. Federal Circuit reversed a district court\u2019s finding that Bascom\u2019s patent for filtering internet content failed <b>step two<\/b> of the <i>Mayo\/Alice<\/i> The U.S. Federal Circuit stated that &#8220;the inventive concept inquiry requires more than recognizing that each claim element, by itself, was known in the art. . . an inventive concept can be found in the <i>non-conventional and non-generic arrangement of known, conventional pieces<\/i>.&#8221; Life science experts believe this finding can also help life science patents.<\/li>\n<\/ul>\n<p>Our panelists will give specific tips for drafting and prosecuting patents in their industries to avoid Section 101 rejections, resulting in patents that will withstand patent-eligibility attacks in litigation. The life science webinar will include discussion of <b>both therapeutics and diagnostics<\/b>, and the software webinar will include discussion of <b>several recent useful ex parte PTAB decisions<\/b> that overturned examiners Section 101 rejections.<\/p>\n<p><b><span style=\"color: #000000;\"><\/span><\/b><\/p>\n<p>Speakers:<\/p>\n<p style=\"padding-left: 30px;\">Deborah Martin, <em>Pfizer Inc.<\/em><br \/>\nChristopher Jeffers, <em>Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C.<\/em><br \/>\nWarren Woessner, <em>Schwegman, Lundberg &amp; Woessner, P.A.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Supreme Court\u2019s recent decision not to grant certiorari  [&#8230;]<\/p>\n","protected":false},"author":73,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16923","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Life Sciences &amp; Section 101: The Way Ahead - Intellectual Property Owners Association<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Life Sciences &amp; Section 101: The Way Ahead - Intellectual Property Owners Association\" \/>\n<meta property=\"og:description\" content=\"The U.S. Supreme Court\u2019s recent decision not to grant certiorari [...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/\" \/>\n<meta property=\"og:site_name\" content=\"Intellectual Property Owners Association\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/IPOAssociation\/\" \/>\n<meta property=\"article:published_time\" content=\"2016-08-11T14:00:20+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2016-08-16T17:45:57+00:00\" \/>\n<meta name=\"author\" content=\"Clara Stanfield\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ipo\" \/>\n<meta name=\"twitter:site\" content=\"@ipo\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Clara Stanfield\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/\"},\"author\":{\"name\":\"Clara Stanfield\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/e7c6c4ac1157807d25dced93e3fbd664\"},\"headline\":\"Life Sciences &#038; Section 101: The Way Ahead\",\"datePublished\":\"2016-08-11T14:00:20+00:00\",\"dateModified\":\"2016-08-16T17:45:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/\"},\"wordCount\":382,\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/\",\"name\":\"Life Sciences & Section 101: The Way Ahead - Intellectual Property Owners Association\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\"},\"datePublished\":\"2016-08-11T14:00:20+00:00\",\"dateModified\":\"2016-08-16T17:45:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/section-101-way-ahead\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ipo.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Life Sciences &#038; Section 101: The Way Ahead\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#website\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"name\":\"Intellectual Property Owners Association\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ipo.org\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#organization\",\"name\":\"Intellectual Property Owners Association\",\"url\":\"https:\\\/\\\/ipo.org\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"contentUrl\":\"https:\\\/\\\/ipo.org\\\/wp-content\\\/uploads\\\/2019\\\/06\\\/ipo_logo.png\",\"width\":570,\"height\":226,\"caption\":\"Intellectual Property Owners Association\"},\"image\":{\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/IPOAssociation\\\/\",\"https:\\\/\\\/x.com\\\/ipo\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ipoassociation\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ipo.org\\\/#\\\/schema\\\/person\\\/e7c6c4ac1157807d25dced93e3fbd664\",\"name\":\"Clara Stanfield\",\"description\":\"33796\",\"url\":\"https:\\\/\\\/ipo.org\\\/index.php\\\/author\\\/clara\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Life Sciences & Section 101: The Way Ahead - Intellectual Property Owners Association","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/","og_locale":"en_US","og_type":"article","og_title":"Life Sciences & Section 101: The Way Ahead - Intellectual Property Owners Association","og_description":"The U.S. Supreme Court\u2019s recent decision not to grant certiorari [...]","og_url":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/","og_site_name":"Intellectual Property Owners Association","article_publisher":"https:\/\/www.facebook.com\/IPOAssociation\/","article_published_time":"2016-08-11T14:00:20+00:00","article_modified_time":"2016-08-16T17:45:57+00:00","author":"Clara Stanfield","twitter_card":"summary_large_image","twitter_creator":"@ipo","twitter_site":"@ipo","twitter_misc":{"Written by":"Clara Stanfield","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/#article","isPartOf":{"@id":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/"},"author":{"name":"Clara Stanfield","@id":"https:\/\/ipo.org\/#\/schema\/person\/e7c6c4ac1157807d25dced93e3fbd664"},"headline":"Life Sciences &#038; Section 101: The Way Ahead","datePublished":"2016-08-11T14:00:20+00:00","dateModified":"2016-08-16T17:45:57+00:00","mainEntityOfPage":{"@id":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/"},"wordCount":382,"publisher":{"@id":"https:\/\/ipo.org\/#organization"},"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/","url":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/","name":"Life Sciences & Section 101: The Way Ahead - Intellectual Property Owners Association","isPartOf":{"@id":"https:\/\/ipo.org\/#website"},"datePublished":"2016-08-11T14:00:20+00:00","dateModified":"2016-08-16T17:45:57+00:00","breadcrumb":{"@id":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ipo.org\/index.php\/section-101-way-ahead\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ipo.org\/index.php\/section-101-way-ahead\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ipo.org\/"},{"@type":"ListItem","position":2,"name":"Life Sciences &#038; Section 101: The Way Ahead"}]},{"@type":"WebSite","@id":"https:\/\/ipo.org\/#website","url":"https:\/\/ipo.org\/","name":"Intellectual Property Owners Association","description":"","publisher":{"@id":"https:\/\/ipo.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ipo.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ipo.org\/#organization","name":"Intellectual Property Owners Association","url":"https:\/\/ipo.org\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/","url":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","contentUrl":"https:\/\/ipo.org\/wp-content\/uploads\/2019\/06\/ipo_logo.png","width":570,"height":226,"caption":"Intellectual Property Owners Association"},"image":{"@id":"https:\/\/ipo.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/IPOAssociation\/","https:\/\/x.com\/ipo","https:\/\/www.linkedin.com\/company\/ipoassociation\/"]},{"@type":"Person","@id":"https:\/\/ipo.org\/#\/schema\/person\/e7c6c4ac1157807d25dced93e3fbd664","name":"Clara Stanfield","description":"33796","url":"https:\/\/ipo.org\/index.php\/author\/clara\/"}]}},"_links":{"self":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/16923","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/users\/73"}],"replies":[{"embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/comments?post=16923"}],"version-history":[{"count":1,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/16923\/revisions"}],"predecessor-version":[{"id":16924,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/posts\/16923\/revisions\/16924"}],"wp:attachment":[{"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/media?parent=16923"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/categories?post=16923"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ipo.org\/index.php\/wp-json\/wp\/v2\/tags?post=16923"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}